Use of oral anticoagulants in patients with valvular atrial fibrillation: Findings from the NCDR PINNACLE Registry

Document Type

Letter to the Editor

Department

Office of the Provost; Cardiology

Abstract

Recent data suggest direct oral anticoagulants are as safe and efficacious as warfarin among select patients with valvular heart disease and atrial fibrillation (AF). However, real-world treatment patterns of AF stroke prophylaxis in the setting of valvular AF are currently unknown. Accordingly, using the prospective, ambulatory National Cardiovascular Data Registry Practice Innovation and Clinical Excellence (PINNACLE) Registry, we sought to characterize overall use, temporal trends in use, and the extent of practice-level variation in the use of any direct oral anticoagulant and warfarin among patients with valvular AF from January 1, 2013, to March 31, 2019.

Comments

Issue Num are not provided by the author/publisher. This work was published before the author joined Aga Khan University

Publication (Name of Journal)

American Heart Journal

Link to Full Text

Share

COinS